期刊文献+

NQO1和HO-1在T细胞淋巴瘤中的表达及意义 被引量:4

Expression and significance of NAD (P) H:quinone oxidoreductase 1 and heme oxygenase-1 proteins in T-cell lymphoma
下载PDF
导出
摘要 目的:探讨醌氧化还原酶1[NAD(P)H:quinine oxidoreductase 1,NQO1]与血红素加氧酶-1(heme oxygenase-1,HO-1)在T细胞淋巴瘤(T-cell lymphoma,TCL)中的表达及其临床病理特征间的关系。方法:回顾性分析2012年12月至2018年5月甘肃省人民医院确诊的61例TCL患者的临床资料。采用免疫组织化学法检测NQO1和HO-1在61例TCL组织(TCL组)及20例淋巴结反应性增生组织(对照组)中的表达水平。结果:NQO1和HO-1在TCL组织中的阳性表达率均明显高于淋巴结反应性增生组织,差异具有统计学意义(P<0.05);NQO1与TCL临床分期和B症状有关(P<0.05);HO-1与TCL的临床分期、骨髓侵犯和B症状密切相关(P<0.05);二者与TCL患者的年龄、性别、乳酸脱氢酶水平及病理分型无关(P>0.05);NQO1和HO-1的表达存在相关性(r=0.264;P=0.040)。结论:NQO1和HO-1在TCL中高表达,可能互相作用参与TCL的发生发展。 Objective:To investigate the expression of NAD(P)H:quinone oxidoreductase 1(NQO1)and heme oxygenase-1(HO-1)in Tcell lymphoma(TCL),and investigate the correlation between these two indicators and other clinicopathological parameters in TCL.Methods:Clinical data of 61 patients with TCL who were initially diagnosed in Gansu Provincial Hospital were analyzed retrospectively.Immunohistochemical examination was performed to detect NQO1 and HO-1 expression levels in 61 TCL tissues(TCL group)and 20 lymph node reactive hyperplasia tissues(control group).Results:Positive expression rates of NQO1 and HO-1 were significantly higher in TCL tissues than in lymph node reactive hyperplasia tissues(P<0.05).NQO1 expression was closely related with Ann-Arbor clinical stage and B symptoms(P<0.05);HO-1 expression was correlated with clinical stage,bone marrow invasion,and B symptoms(P<0.05).NQO1 and HO-1 expression levels were not related to age,sex,lactate dehydrogenase level,and pathological type(P>0.05);there was a correlation between NQO1 and HO-1 expression(r=0.264;P=0.040).Conclusions:NQO1 and HO-1 are highly expressed in TCL and may interact and contribute to the occurrence and development of TCL.
作者 张婧 薛丽 党雅梅 赵凤辉 李红玲 Jing Zhang;Li Xue;Yamei Dang;Fenghui Zhao;Hongling Li(Department of Oncology,Gansu Provincial Hospital,Lanzhou 730000,China;Department of Pathology,Gansu Provincial Hospital,Lanzhou 730000,China)
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2018年第20期1033-1037,共5页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金项目(编号:81560498 81260342)资助~~
关键词 T细胞淋巴瘤 NQO1 HO-1 免疫组织化学 T cell lymphoma NAD(P)H:quinone oxidoreductase 1(NQO1) heme oxygenase-1(HO-1) immunohistochemistry
  • 相关文献

参考文献3

二级参考文献34

  • 1吴玉霞,高怡瑾,赵金彩,金锡鹏,夏昭林.GSTM1、GYP2E1和NQO1基因多态性与儿童白血病发病风险的初步研究[J].中华流行病学杂志,2004,25(9):819-819. 被引量:4
  • 2张娟,浦跃朴,尹立红,朱方艳,郭吉.基因多态性与成人急性白血病易感性关系的研究[J].肿瘤,2005,25(4):346-350. 被引量:11
  • 3杨琳,徐世才,刘旭平,张美荣,张悦,肖志坚.GSTT1、GSTM1、NQO1、RAD51和XRCC3基因多态性与慢性粒细胞白血病发生关系的研究[J].国际输血及血液学杂志,2006,29(1):2-5. 被引量:4
  • 4朱方艳,张娟,尹立红,浦跃朴.MPO和NAT2基因多态性与成人急性白血病易感性[J].中国公共卫生,2006,22(5):584-586. 被引量:12
  • 5[1]Jaiswal AK, McBride OW, Adesnik M, et al. Human dioxininducible cytosolic NAD(P)H: menadione oxidoreductase. cDNA sequence and localization of gene to chromosome 16[J]. J Biol Chem, 1988, 263(27): 13572~13578
  • 6[2]Tvaver RD, Horikosh T, Danenberg KD, et al. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity [J]. Cancer Res, 1992, 52(4): 797~802
  • 7[3]Monks TJ, Hanzlik RP, Cohen GM, et al. Quinone chemistry and toxicity[J]. Toxicol Appl Pharmacol, 1992, 112(1): 2~16
  • 8[4]Siegel D, Anwar A, Winski SL, et al. Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD (P)H:quinone oxidoreductase 1 [J]. Mol Pharmacol, 2001, 59(2):263 ~268
  • 9[5]Kuehl BL, Paterson JW, Peacock JW, et al. Presence of a heterozygous substitution and its relationship to DT-diaphorase activity[J]. Br J Cancer, 1995, 72(3): 555~561
  • 10[6]Kelsey KT, Ross D, Traver RD, et al. Ethnic variation in the prevalence of a common NAD (P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy[J]. BrJ Cancer, 1997, 76(7): 852~854

共引文献31

同被引文献38

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部